Full Name
Lingzhi Wang
Variants
Wang Lingzhi
Wang, L.Z.
Wang, L.-Z.
Wang, L.
 
 
 
Email
csiwl@nus.edu.sg
 
 

Publications

Refined By:
Date Issued:  [2000 TO 2021]
File Format:  Adobe PDF
Department:  MEDICINE

Results 1-20 of 29 (Search time: 0.018 seconds).

Issue DateTitleAuthor(s)
12017A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinomaDai X.; Wang L. ; Deivasigamni A.; Looi C.Y.; Karthikeyan C.; Trivedi P.; Chinnathambi A.; Alharbi S.A.; Arfuso F.; Dharmarajan A.; Goh B.C. ; Hui K.M. ; Kumar A.P. ; Mustafa M.R.; Sethi G. 
210-Oct-2016A novel combinatorial strategy using Seliciclib (R) and Belinostat (R) for eradication of non-small cell lung cancer via apoptosis induction and BID activationOng, Pei-Shi ; Wang, Lingzhi ; Chia, Deborah Miao-Hui; Seah, Jolyn Yu-Xin; Kong, Li-Ren ; Thuya, Win-Lwin ; Chinnathambi, Arunachalam; Lau, Jie-Ying Amelia ; Wong, Andrea Li-Ann ; Yong, Wei-Peng ; Yang, Daiwen ; Ho, Paul Chi-Lui ; Sethi, Gautam ; Goh, Boon-Cher 
32019A novel small-molecule inhibitor of trefoil factor 3 (TFF3) potentiates MEK1/2 inhibition in lung adenocarcinomaZhang, M.; Wang, B.; Chong, Q.-Y. ; Pandey, V.; Guo, Z.; Chen, R.-M.; Wang, L. ; Wang, Y.; Ma, L.; Kumar, A.P. ; Zhu, T.; Wu, Z.-S.; Yin, Z.; Basappa; Goh, B.-C. ; Lobie, P.E. 
42020A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumoursAng, Y.L.E.; Ho, G.F.; Soo, R.A. ; Sundar, R. ; Tan, S.H.; Yong, W.P. ; Ow, S.G.W. ; Lim, J.S.J. ; Chong, W.Q.; Soe, P.P.; Tai, B.C. ; Wang, L. ; Goh, B.C. ; Lee, S.-C. 
52018A review on liquid chromatography-tandem mass spectrometry methods for rapid quantification of oncology drugsWong, A.L.-A ; Xiang, X; Ong, P.S ; Mitchell, E.Q.Y; Syn, N; Wee, I; Kumar, A.P ; Yong, W.P ; Sethi, G ; Goh, B.C ; Ho, P.C.-L ; Wang, L 
62018A sensitive liquid chromatography-tandem mass spectrometry method for the determination of nimbolide in mouse serum: Application to a preclinical pharmacokinetics studyWang, L ; Khoa Phan, D.-D; Syn, N; Xiang, X; Song, H; Thuya, W.L ; Yang, S ; Wong, A.L.-A ; Kumar, A.P ; Yong, W.P ; Sethi, G ; Ho, P.C.-L ; Goh, B.C 
72018Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressorSubhash, V.V; Yeo, M.S; Wang, L ; Tan, S.H; Wong, F.Y; Thuya, W.L ; Tan, W.L; Peethala, P.C ; Soe, M.Y; Tan, D.S.P; Padmanabhan, N ; Baloglu, E; Shacham, S; Tan, P ; Koeffler, H.P ; Yong, W.P 
82016Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its developmentWang, L ; Khoa Phan, D.D; Zhang, J; Ong, P.-S ; Thuya, W.L ; Soo, R.A ; Wong, A.L.-A ; Yong, W.P ; Lee, S.C ; Ho, P.C.-L ; Sethi, G ; Goh, B.C 
97-Apr-2021Characterization and Establishment of a Novel EBV Strain Simultaneously Associated With Nasopharyngeal Carcinoma and B-Cell LymphomaYu, Fenggang ; Syn, Nicholas L; Lu, Yanan; Chong, Qing Yun ; Lai, Junyun ; Tan, Wei Jian ; Goh, Boon Cher ; MacAry, Paul A ; Wang, Lingzhi ; Loh, Kwok Seng 
102017Combined use of irinotecan with histone deacetylase inhibitor belinostat could cause severe toxicity by inhibiting SN-38 glucuronidation via UGT1A1Wang, L ; Chan, C.E.L; Wong, A.L.-A ; Wong, F.C; Lim, S.W ; Chinnathambi, A; Alharbi, S.A; Lee, L.S.-U ; Soo, R ; Yong, W.P ; Lee, S.C ; Ho, P.C.-L ; Sethi, G ; Goh, B.C 
1113-Aug-2019Different treatment efficacies and side effects of cytotoxicchemotherapyWang Lingzhi ; Chong Qing Yun ; Goh Boon Cher ; Soo Ross ; Li Low-Jia
1227-Sep-2021Epigenetic derepression converts PPAR gamma into a druggable target in triple-negative and endocrine-resistant breast cancersLoo, Ser Yue; Syn, Nicholas L; Koh, Angele Pei-Fern ; Teng, Janet Cheng-Fei ; Deivasigamani, Amudha; Tan, Tuan Zea ; Thike, Aye Aye ; Vali, Shireen ; Kapoor, Shweta; Wang, Xiaoyuan ; Wang, Jiong Wei ; Tan, Puay Hoon ; Yip, George W ; Sethi, Gautam ; Huang, Ruby Yun-Ju ; Hui, Kam Man ; Wang, Lingzhi ; Goh, Boon Cher ; Kumar, Alan Prem 
132015Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkersLi F. ; Shanmugam M.K. ; Siveen K.S. ; Wang F. ; Ong T.H.; Loo S.Y. ; Swamy M.M.M.; Mandal S.; Kumar A.P. ; Goh B.C. ; Kundu T.; Ahn K.S.; Wang L.Z. ; Hui K.M. ; Sethi G. 
1430-Jan-2013Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer PatientsWang, L.-Z. ; Ramírez, J.; Yeo, W.; Chan, M.-Y.M.; Thuya, W.-L. ; Lau, J.-Y.A.; Wan, S.-C.; Wong, A.L.-A.; Zee, Y.-K.; Lim, R.; Lee, S.-C. ; Ho, P.C. ; Lee, H.-S.; Chan, A.; Ansher, S.; Ratain, M.J.; Goh, B.-C.
1514-Aug-2020Integration of antiangiogenic therapy with cisplatin and gemcitabine chemotherapy in patients with nasopharyngeal carcinoma.Chong, Wan Qin; Lim, Chwee Ming ; Sinha, Arvind Kumar ; Tan, Chee Seng ; Chan, Gloria Hui Jia; Huang, Yiqing; Barr Kumarakulasinghe, Nesaretnam; Sundar, Raghav ; Jeyasekharan, Anand D ; Loh, Woei Shyang ; Tay, Joshua K. ; Yadav, Kritika ; Wang, Lingzhi ; Wong, Andrea L. ; Kong, Li Ren ; Soo, Ross Andrew ; Lau, Jieying Amelia ; Soon, Yu Yang ; Goh, Robby Miguel; Ho, Francis Cho Hao ; Chong, Siew Meng ; Lee, Soo-Chin ; Loh, Kwok Seng ; Tai, Bee Choo ; Lim, Yaw Chyn ; Goh, Boon Cher 
165-Dec-2019MELK mediates the stability of EZH2 through site-specific phosphorylation in extranodal natural killer/T-cell lymphomaLi, Boheng ; Yan, Junli ; The, Phyu; Fan, Shuangyi ; Chung, Tae-Hoon; Mustafa, Nurulhuda; Lin, Baohong; Wang, Lingzhi ; Eichhorn, Pieter Johan Adam; Goh, Boon-Cher ; Ng, Siok-Bian ; Kappei, Dennis; Chng, Wee-Joo 
172017Non-malignant epithelial cells preferentially proliferate from nasopharyngeal carcinoma biopsy cultured under conditionally reprogrammed conditionsYu F. ; Lu Y.; Tao L. ; Jiang Y.-Y. ; Lin D.-C.; Wang L. ; Petersson F. ; Yoshiyama H.; Koeffler P.H.; Goh B.-C. ; Loh K.S. 
182018Pan-CDK inhibition augments cisplatin lethality in nasopharyngeal carcinoma cell lines and xenograft modelsSyn N.L.; Lim P.L.; Kong L.R.; Wang L. ; Wong A.L.-A. ; Lim C.M. ; Loh T.K.S. ; Siemeister G.; Goh B.C. ; Hsieh W.-S. 
1928-Mar-2018Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signalingWang, Lingzhi ; Syn, Nicholas Li-Xun; Subhash, Vinod Vijay; Any, Yijia; Thuya, Win Lwin ; Cheow, Esther Sok Hwee ; Kong, Li Ren ; Yu, Fenggang ; Peethala, Praveen C. ; Wong, Andrea Li-Ann ; Laljibhai, Hirpara J. ; Chinnathambi, Arunachalam; Ong, Pei Shi ; Ho, Paul Chi-Lui ; Sethi, Gautam ; Yong, Wei Peng ; Goh, Boon Cher 
202016Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancerWong A.L.A. ; Sundar R.; Wang T.-T. ; Ng T.-C. ; Zhang B. ; Tan S.-H. ; Soh T.I.P.; Pang A.S.L.; Tan C.-S.; Ow S.G.W.; Wang L. ; Mogro J.; Ho J.; Jeyasekharan A.D. ; Huang Y.; Thng C.-H. ; Chan C.-W. ; Hartman M. ; Iau P.; Buhari S.A. ; Goh B.-C. ; Lee S.-C.